Assyro AI

Orange Book product · Generic (ANDA)

DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Generic (ANDA)ANDA 211546TE AB2RX SPECGX LLC

At a glance

Aug 31, 2023

Approved

Generic (ANDA)

Application

AB2

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Aug 31, 2023

    2 yr 10 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Strength

3.125MG;3.125MG;3.125MG;3.125MG

Dosage form

CAPSULE, EXTENDED RELEASE

Route

ORAL

TE code

AB2

Application

ANDA 211546

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.